GENECHEM

genechem-logo

GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund's objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.

#People #Financial #More

GENECHEM

Social Links:

Industry:
Genetics

Founded:
1997-01-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS


Current Employees Featured

fabienne-perreau_image

Fabienne Perreau
Fabienne Perreau Administrative Assistant @ GeneChem
Administrative Assistant

martial-lacroix_image

Martial Lacroix
Martial Lacroix General Partner @ GeneChem
General Partner

inรจs-holzbaur_image

Inรจs Holzbaur
Inรจs Holzbaur General Partner @ GeneChem
General Partner

john-clement_image

John Clement
John Clement General Partner @ GeneChem
General Partner

not_available_image

Patricia Laplante
Patricia Laplante Project Manager @ GeneChem
Project Manager

elizabeth-douville_image

Elizabeth Douville
Elizabeth Douville General Partner @ GeneChem
General Partner

maxime-pesant_image

Maxime Pesant
Maxime Pesant Vice-President, Finance @ GeneChem
Vice-President, Finance

kevin-mcbride_image

Kevin McBride
Kevin McBride Project Manager @ GeneChem
Project Manager

Investments List

Date Company Article Money raised
2008-09-03 Osprey Pharmaceuticals USA GeneChem investment in Series A - Osprey Pharmaceuticals USA 11 M USD
2007-11-14 Ambit Biosciences GeneChem investment in Series D - Ambit Biosciences 49.3 M USD
2007-01-30 Osprey Pharmaceuticals USA GeneChem investment in Venture Round - Osprey Pharmaceuticals USA 9 M USD
2007-01-18 Cytochroma GeneChem investment in Series C - Cytochroma 21 M CAD
2006-12-01 Xanthus Pharmaceuticals GeneChem investment in Series B - Xanthus Pharmaceuticals 25 M USD
2005-05-12 Ambit Biosciences GeneChem investment in Series C - Ambit Biosciences 31 M USD
2004-04-27 NewBiotics GeneChem investment in Series E - NewBiotics 4.57 M USD
2003-12-12 Xanthus Pharmaceuticals GeneChem investment in Series B - Xanthus Pharmaceuticals 30.8 M USD
2003-07-03 LymphoSign GeneChem investment in Series A - LymphoSign 5.9 M USD
2002-12-09 Idun Pharmaceuticals GeneChem investment in Series A - Idun Pharmaceuticals 22.8 M USD

More informations about "GeneChem"

GeneChem - Crunchbase Company Profile & Funding

GeneChem Inc. is specialized in the development of health-related substances such as functional oligosaccharides, new bio-medicines, and gene therapy โ€ฆSee details»

GeneChem - Crunchbase Investor Profile & Investments

GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics โ€ฆSee details»

GeneChem - Venbridge

GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem โ€ฆSee details»

Genechem (China) - Crunchbase Company Profile

Genechem (China) closed its last funding round on Apr 3, 2020 from a Series C round. Who are Genechem (China) 's competitors? Alternatives and possible โ€ฆSee details»

Genechem - 2025 Company Profile, Funding & Competitors - Tracxn

Genechem - Products and services in molecular biology. Raised a total funding of $56.4M over 2 rounds from 4 investors. Founded by Honghua Qu in the year 2002. Genechem has 857 โ€ฆSee details»

GeneChem Inc. - LinkedIn

GeneChem has developed health-related functional materials and innovative drugs such as functional oligosaccharides, new bio-drugs and gene therapy based on nucleic acid chemistry, phosphate ...See details»

Genechem - VentureRadar

Founded in 2002, now with over 500 employees, Genechem works closely with Research Oncologists to translate clinical research into therapeutics addressing high clinical unmet โ€ฆSee details»

Gene Chem Company Profile 2024: Valuation, Funding โ€ฆ

Gene Chem General Information Description. Provider of disease and genetic research services. The company focuses on the research and development of genetic diseases and develops innovative drugs for cancer treatment, โ€ฆSee details»

GeneChem investment portfolio - PitchBook

GeneChem General Information Company Description. Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada. The firm seeks to invest in United States, Canada, and โ€ฆSee details»

GeneChem Company Profile | Westmount, QC, Canada

GeneChem Company Profile | Westmount, QC, Canada | Competitors, Financials & Contacts - Dun & BradstreetSee details»

GeneChem Management - Private Equity International

GeneChem Management. News, insights, analysis and data. GeneChem Management overview. Established in 1997, GeneChem Management was a Canada-based private equity firm, โ€ฆSee details»

Shanghai Genchem Co., Ltd. (Genechem) Announces Global

SHANGHAI, April 6,, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel โ€ฆSee details»

GeneChem - Investments, Portfolio & Company Exits - Crunchbase

GeneChem 's most notable exits include Lexicon Pharmaceuticals, Triad Life Sciences, and Idun Pharmaceuticals. Which industries has this organization had the most exits in? ShowSee details»

GeneChem - Investor in Montreal, Quebec - Ask For Funding

GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds: GeneChem Technologies, GeneChem Therapeutics, โ€ฆSee details»

Genechem | VentureRadar

Founded in 2002, now with over 500 employees, Genechem works closely with Research Oncologists to translate clinical research into therapeutics addressing high clinical unmet โ€ฆSee details»

GeneChem - Funding, Financials, Valuation & Investors - Crunchbase

Nov 16, 2007 GeneChem has made 3 investments. Their most recent investment was on Nov 16, 2007 , when BioVex raised $35M . How many investments has this organization made โ€ฆSee details»

[PRNewswire] Shanghai Genechem Co., Ltd. (Genechem) โ€ฆ

Apr 7, 2021 Genechem is a leading innovation research company focused on target discovery/validation, development of antibody and cell therapy products against novel targets, โ€ฆSee details»

Shanghai Genechem Co., Ltd. (Genechem) Announces Global โ€ฆ

SHANGHAI, April 6, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel โ€ฆSee details»

Shanghai Genechem Co., Ltd. (Genechem) Announces Global โ€ฆ

Apr 6, 2021 Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, announced the execution โ€ฆSee details»

GeneChem - Contacts, Employees, Board Members, Advisors

GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»